The PPARα‑dependent rodent liver tumor response is not relevant to[...]
Health Risk Reduction and Cost Analysis of the Proposed Perchlorate[...]
08/19/2022 | Press release | Distributed by Public on 08/19/2022 02:34
Please select the service you want to use:
Smartlinks | Spectral MD Holdings Ltd. | News | Health | Local News | Company News | Public Companies | Medical Technology Companies | London Stock Exchange (LSE) | Börse Frankfurt | Cboe Off Exchange
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact